Regorafenib FDA approval date

The FDA approved Regorafenib (Stivarga®) on 27 Sep 2012.

FDA approval date
27 Sep 2012

Drug identity checked against registry records

Also recorded as Stivarga®

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal CancerNCT05425940ExelixisPhase 3Active not recruiting2026-06-16Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2012-09-27DayRegorafenibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA203085", "applicant_as_listed_by_fda": "BAYER HLTHCARE", "brand_names": ["STIVARGA"], "active_ingredients": ["REGORAFENIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120927", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026